• Home
  • Access
JAPANESE
  • Technologies
  • Products
  • About PSS
  • Investor Relations
  • FAQ / Contact

Home > Investor Relations > Press Release > PSS reaches basic agreement with Nordiag ASA on development of reagents and their protocols for next generation sequencer

Investor Relations

Press Release

Download PDF (63.7 KB)
Feb 10, 2011

PSS reaches basic agreement with Nordiag ASA on development of reagents and their protocols for next generation sequencer

February 10, 2011- Precision System Science, Co., Ltd (PSS) announced today that PSS and Nordiag ASA (Oslo, Norway) have entered into basic development agreement of reagents for next generation sequencer, development of such reagents protocols for SX-8G Compact and the distribution of the reagents by both companies.

 

The genetic analysis market, using next generation sequencer, is currently $1 billion USD and is estimated to reach $4 billion in 2015.  As sample preparation before next generation sequencer is generally performed manually, automating the process is highly demanded for further spread of such analysis.  Thus, PSS has started marketing of SX-8G Compact, an automatic sample preparation instrument for next generation sequencer in collaboration with IntegenX Inc.  SX-8G Compact, which originally was developed as a DNA extraction device using PSS’s patented Magtration® Technology, is well suited to expand the market for automation of next generation sequencing library preparation, demonstrating its multi-purpose capability.

 

According to the agreement, Nordiag ASA develops on the behalf of PSS reagents for next generation sequencer, development of such reagents protocols for SX-8G Compact.  After validated by the third party institutions, PSS should apply the reagents and protocols to SX-8G Compact.  PSS, through the development consignment to Nordiag ASA, has entered into reagents market along with the instrument of sample preparation for next generation sequencer, seeking further use of genetic analysis.

 

Contact : ir@pss.co.jp

  • Home
  • Technologies
  • Products
  • About PSS
  • Investor Relations
  • FAQ / Contact
TOP